BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 3rd Quarter - Report

TEVA PHARMACEUTICALS USA, INC.

via COLAS & ASSOCIATES, LLC

3rd Quarter (July 1 - Sep 30) · 2024Posted Oct 16, 2024Filing document ↗LDA record ↗

Income$40Kfee reported

Client

Name: TEVA PHARMACEUTICALS USA, INC.
Description: Drug manufacturer
Location: New Jersey · United States of America

Registrant

Firm: COLAS & ASSOCIATES, LLC
Location: Arlington, Virginia, United States of America

Lobbying activities

1 issue

Health Issues
- Issues related to drug patents and labeling requirements.
LobbyistsBRIAN COLAS
TargetedSENATE

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

TEVA PHARMACEUTICALS USA, INC. — Lobbying — Receipts Report